LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

85.11 -4.13

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

84.1

Max

88.56

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+55.81% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.2B

11B

Ankstesnė atidarymo kaina

89.24

Ankstesnė uždarymo kaina

85.11

Naujienos nuotaikos

By Acuity

50%

50%

165 / 350 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-20 17:19; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026-03-20 16:56; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026-03-20 16:45; UTC

Svarbiausios naujienos

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026-03-20 16:22; UTC

Svarbiausios naujienos

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026-03-20 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 20:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 19:55; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026-03-20 19:28; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026-03-20 19:28; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 18:39; UTC

Rinkos pokalbiai

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026-03-20 18:31; UTC

Įsigijimai, susijungimai, perėmimai

Honeywell Announces Pricing of Debt Tender Offers >HON

2026-03-20 18:19; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026-03-20 18:15; UTC

Rinkos pokalbiai

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026-03-20 17:57; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Inches Up -- Market Talk

2026-03-20 17:04; UTC

Svarbiausios naujienos

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026-03-20 16:20; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Basic Materials Roundup: Market Talk

2026-03-20 16:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Health Care Roundup: Market Talk

2026-03-20 15:40; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026-03-20 15:30; UTC

Uždarbis

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026-03-20 15:26; UTC

Rinkos pokalbiai
Uždarbis
Svarbiausios naujienos

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026-03-20 15:26; UTC

Įsigijimai, susijungimai, perėmimai

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026-03-20 15:25; UTC

Rinkos pokalbiai

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026-03-20 15:19; UTC

Rinkos pokalbiai
Svarbiausios naujienos

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026-03-20 14:58; UTC

Svarbiausios naujienos

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026-03-20 14:55; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Lower as Speculative Pullback Extends -- Market Talk

2026-03-20 14:54; UTC

Įsigijimai, susijungimai, perėmimai

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026-03-20 14:53; UTC

Įsigijimai, susijungimai, perėmimai

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026-03-20 14:46; UTC

Rinkos pokalbiai

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026-03-20 14:45; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

55.81% į viršų

12 mėnesių prognozė

Vidutinis 132.72 USD  55.81%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 20 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

20 ratings

19

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

165 / 350 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat